Last updated: August 2026
Global rank: Worldwide · 2026-08
#1,213,345
AI visibility: Grade C
67
SEO health: Not audited
—
Visits
286
per month, estimated
Keywords
215
ranking in Google
Organic share
100%
286 organic visits
LLMS.txt
Published
151 lines AI engines can read
You're seeing the free preview of adello.com
adello.com Web Traffic Statistics
Key findings
- Adello (Biotechnology) is ranked #1,213,345 worldwide in our August 2026 domain ranking, up 47,307 places from #1,260,652 in July 2026.
- It is estimated to receive about 286 visits a month from search, 100% of it organic, across 215 ranking keywords.
- Its AI visibility score is 67 out of 100 (grade C), with a published llms.txt of 151 lines.
| Month | Rank | Move |
|---|---|---|
| August 2026 | #1,213,345 | ▲ 47,307 |
| July 2026 | #1,260,652 | ▲ 12,392 |
| June 2026 | #1,273,044 | — |
| May 2026 | #1,273,044 | ▼ 19,817 |
| April 2026 | #1,253,227 | — |
What this company does
Adello stands out in the biotech world by designing multi-specific antibodies that hit several targets at once, something traditional drugs struggle with. This tech comes from a smart platform they've built in-house, letting them tweak and test molecules faster than most competitors. It started with a handful of scientists frustrated by single-target limitations in cancer and autoimmune fights. Now, their lead candid…
adello.com Traffic and Visitor Engagement
adello.com draws an estimated 286 visits a month from search engines. Effectively all of it is organic — about 286 visits from unpaid results. Spread across 215 ranking keywords, that averages roughly 1.3 organic visits per keyword.
Monthly visits
286
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
286
100% of all traffic
Paid visits
0
No paid search detected
Organic vs paid
100%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
adello.com AI Visibility
On our AI visibility scale adello.com earns 67 of 100 points, a grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (Not scanned yet), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).
Grade C
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
Present
7/8 core fields
Not scanned yet
Not scanned yet
Detected
Fix these first
- → Complete your company profile so AI answers about you stay accurate.
- → Run a full SEO scan — technical health is unscored until then.
adello.com LLMS.txt
The llms.txt on adello.com runs to 151 lines (7,434 characters) across 12 sections, last generated in May 2026. It introduces the site as "Adello". It tells AI engines the business works in Biotechnology, Pharmaceuticals, Immuno-oncology, Autoimmune Therapeutics and Antibody Engineering. It describes 4 products, including Adello-101, Adello-201 and Adello-301. Services it lists include Antibody Discovery, Preclinical Development, IND Enablement and Partnered Manufacturing. The audience it names is Pharma executives, Oncologists, Biotech investors (Global). Technologies it mentions include Google Analytics, Cloudflare, jQuery, LinkedIn Pixel and YouTube API. The keywords it claims start with "multi-specific antibodies", "bispecific antibodies", "biotech" and "clinical stage".
Status
Published
AI engines can read it
Lines
151
In the file
Size
7.4K
Characters
Sections
12
Updated May 3, 2026
What the file says
# Adello ## About Adello's diving deep into next-gen antibody tech, crafting molecules that bind multiple proteins to outsmart diseases like never before. Forget one-trick ponies—their multi-specifics mimic the body's own defenses for better punch. The platform they use speeds up iteration, from concept to clinic in record time. Seasoned researchers lead the charge, pulling from years at top-tier labs and companies. Oncology's their main battleground right now, with a lead asset dosing patients in Phase 1. Autoimmune apps are next, promising relief where steroids fall short. They collaborate with contract pros for scaling but own the innovation. Ultimately, it's about delivering therapies that stick, with fewer doses needed. Buzz from early data has VCs circling for more rounds. Spun from academic breakthroughs, Adello keeps that inventive spirit alive. FDA interactions go smooth thanks to regulatory pros on board. Lab culture stresses collaboration and bold risks. Eco-friendly processes are baked in from day one. Follow their YouTube for pipeline peeks and science shorts. LinkedIn's where they network and share wins. Steady progress positions them well amid biotech volatility. Big readouts loom, potentially catapulting them forward. The multi-target strategy's their secret sauce, drawing serious interest. Adello embodies that gritty pursuit of cures in the Bay Area scene. **
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
- Adello-101N/A
- Adello-201N/A
- Adello-301N/A
- ASM PlatformLicensing
Services it tells AI about
- Antibody DiscoveryContact for pricing
- Preclinical DevelopmentContact for pricing
- IND EnablementContact for pricing
- Partnered ManufacturingContact for pricing
Competitors it names
Audience it targets
Pharma executives, Oncologists, Biotech investors · Global
Company type
Private
adello.com Organic Keywords
Google lists adello.com for about 215 keywords, which together bring an estimated 286 organic visits a month.
Ranking keywords
215
Found in Google for this domain
Visits they bring
286
Estimated organic visits a month
Top ranking keywords
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
What it ranks for
adello.com Company Profile
Adello stands out in the biotech world by designing multi-specific antibodies that hit several targets at once, something traditional drugs struggle with. This tech comes from a smart platform they've built in-house, letting them tweak and test molecules faster than most competitors. It started with a handful of scientists frustrated by single-target limitations in cancer and autoimmune fights. Now, their lead candid…
Adello was founded in 2021, about 5 years ago, and is headquartered in South San Francisco, United States. Its workforce is listed as between 11 and 50 employees. Its profile files it under Biotechnology, with further tags for Antibody Therapeutics, Oncology and Immunology. Products on record for it: Adello-101 and Adello-201. Total funding on record is $18M. Its tagline reads: "Engineering multi-specific antibodies to tackle hard-to-treat diseases".
- Sector
- Biotechnology
- Headquarters
- South San Francisco, United States
- Founded
- 2021
- Employees
- 11-50
- Revenue
- Not Disclosed
- Funding
- $18M
- Products
- Adello-101, Adello-201
adello.com Traffic by Country
Which markets this brand actually serves, and where the web links to it from.
Top customer markets
AI estimate · live webWe only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Where its backlinks come from
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
adello.com Backlink Analytics
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for adello.com yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
adello.com SEO Audit
How the site itself performs — speed, accessibility and the technical basics both search crawlers and AI crawlers depend on.
This site hasn't been audited yet.
The SEO report runs a fresh crawl and scores over 100 technical checks.
adello.com Competitors and Alternatives
Its own llms.txt names regeneron.com, genmab.com, amgen.com, xencor.com, macrogenics.com and zymeworks.com. Outside its market, the domains ranked closest to it in our worldwide ranking are sourceandsummit.com, stavepuzzles.com, app-pinup-kz.ru and irkutsk-diplom.ru.
Companies ranked next to adello.com
Neighbours of #1,213,345 in our worldwide ranking — each with its own report.
Wait — let's zoom out.
You are looking at one domain. adello.com competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Everything above, for your own domainand the plan to fix it
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
Look up another company
A brand name or a domain — the whole overview loads in seconds.